RHUMBLINE ADVISERS - BIODELIVERY SCIENCES INTL IN ownership

BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 159 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of BIODELIVERY SCIENCES INTL IN
ValueSharesWeighting
Q4 2021$329,000
-15.9%
106,061
-2.1%
0.00%
-100.0%
Q3 2021$391,000
+2.1%
108,348
+1.3%
0.00%0.0%
Q2 2021$383,000
-13.0%
106,978
-5.0%
0.00%0.0%
Q1 2021$440,000
-10.8%
112,597
-4.1%
0.00%0.0%
Q4 2020$493,000
+19.1%
117,387
+5.9%
0.00%0.0%
Q3 2020$414,000
-24.7%
110,897
-12.2%
0.00%0.0%
Q2 2020$550,000
+51.1%
126,242
+31.4%
0.00%0.0%
Q1 2020$364,000
-39.9%
96,074
+0.2%
0.00%0.0%
Q4 2019$606,000
+64.2%
95,923
+9.4%
0.00%0.0%
Q3 2019$369,000
-5.4%
87,670
+4.6%
0.00%0.0%
Q2 2019$390,000
+154.9%
83,819
+77.4%
0.00%
Q1 2016$153,000
-31.4%
47,255
+1.6%
0.00%
-100.0%
Q4 2015$223,000
-2.2%
46,505
+13.6%
0.00%0.0%
Q3 2015$228,000
-29.6%
40,925
+0.7%
0.00%0.0%
Q2 2015$324,000
-25.0%
40,655
-1.1%
0.00%0.0%
Q1 2015$432,000
+3.3%
41,125
+18.3%
0.00%0.0%
Q4 2014$418,000
-27.6%
34,775
+3.0%
0.00%
-50.0%
Q3 2014$577,000
+44.6%
33,750
+2.2%
0.00%
+100.0%
Q2 2014$399,000
+88.2%
33,030
+31.6%
0.00%0.0%
Q1 2014$212,000
+38.6%
25,102
-3.3%
0.00%
Q4 2013$153,000
+8.5%
25,9720.0%0.00%
Q3 2013$141,000
+31.8%
25,972
-1.1%
0.00%
Q2 2013$107,00026,2490.00%
Other shareholders
BIODELIVERY SCIENCES INTL IN shareholders Q2 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,575,000$6,615,0004.38%
1492 Capital Management LLC 790,863$3,322,0001.91%
Rubric Capital Management LP 3,516,124$14,768,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,530,000$40,026,0000.79%
Zebra Capital Management LLC 144,241$606,0000.77%
KNOTT DAVID M 370,230$1,555,0000.70%
Nantahala Capital Management 5,123,671$21,519,0000.67%
SYSTEMATIC FINANCIAL MANAGEMENT LP 3,593,893$15,094,0000.66%
EMC Capital Management 98,933$416,0000.32%
ALGERT GLOBAL LLC 175,170$736,0000.21%
View complete list of BIODELIVERY SCIENCES INTL IN shareholders